AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

A new study finds poor attention spans in childhood, plus certain genes, could play a role in raising the risk for psychosis, ...

Researchers at UCLA Health have found that a person's risk of developing psychotic-like experiences may be influenced by both ...

EMPOWER-1 and EMPOWER-2 Phase 2 clinical trials did not meet their primary endpoint Emraclidine was well-tolerated with an adverse event profile consistent with ...

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the ...

Schizophrenia may increase the abundance of 9 gut microbiota species and reduce the abundance of 2 taxa. A new study evaluating the relationship between the gut microbiome and schizophrenia risk ...

A research team exploring how genes and environmental factors interact in psychiatry has discovered that a history of sexual ...

A research team exploring how genes and environmental factors interact in psychiatry has discovered that a history of sexual trauma and a genetic tendency to develop mental illness are associated with ...

Even if children have certain risk factors, that's still not a guarantee ... childhood attention issues and later psychosis and schizophrenia. However, the new data suggests that attention issues ...

depending on insurance and other factors. One cheaper generic called clozapine is widely considered one of the best treatments for schizophrenia, Krystal said. It is underused in the U.S. compared ...